Class information for:
Level 1: METFORMIN//ANTIDIABETIC BIGUANIDES//GLARGINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4505 1700 45.2 86%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
645 12871 MAMMOGRAPHIC DENSITY//BREAST DENSITY//CANCER CAUSES & CONTROL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 METFORMIN Author keyword 47 12% 22% 376
2 ANTIDIABETIC BIGUANIDES Author keyword 3 100% 0% 3
3 GLARGINE Author keyword 3 16% 1% 19
4 LI KA SHING 2 040 Address 3 60% 0% 3
5 MORTALITY RATE RATIO Author keyword 3 60% 0% 3
6 SM DELLA MISERICORDIA HOSP Address 3 60% 0% 3
7 HONG KONG DIABET OBES Address 2 12% 1% 17
8 INSULIN USE Author keyword 2 67% 0% 2
9 LOW LDL CHOLESTEROL Author keyword 2 67% 0% 2
10 MED ONCOL B SCI DIRECT Address 2 67% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 METFORMIN 47 12% 22% 376 Search METFORMIN Search METFORMIN
2 ANTIDIABETIC BIGUANIDES 3 100% 0% 3 Search ANTIDIABETIC+BIGUANIDES Search ANTIDIABETIC+BIGUANIDES
3 GLARGINE 3 16% 1% 19 Search GLARGINE Search GLARGINE
4 MORTALITY RATE RATIO 3 60% 0% 3 Search MORTALITY+RATE+RATIO Search MORTALITY+RATE+RATIO
5 INSULIN USE 2 67% 0% 2 Search INSULIN+USE Search INSULIN+USE
6 LOW LDL CHOLESTEROL 2 67% 0% 2 Search LOW+LDL+CHOLESTEROL Search LOW+LDL+CHOLESTEROL
7 IMMORTAL TIME BIAS 2 36% 0% 4 Search IMMORTAL+TIME+BIAS Search IMMORTAL+TIME+BIAS
8 SPONTANEOUS CARCINOGENESIS 2 43% 0% 3 Search SPONTANEOUS+CARCINOGENESIS Search SPONTANEOUS+CARCINOGENESIS
9 ANTI DIABETIC MEDICATIONS 1 100% 0% 2 Search ANTI+DIABETIC+MEDICATIONS Search ANTI+DIABETIC+MEDICATIONS
10 BREAST ONCODIABETOLOGY 1 100% 0% 2 Search BREAST+ONCODIABETOLOGY Search BREAST+ONCODIABETOLOGY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SHORT TERM INCIDENCE 30 84% 1% 16
2 ANTIDIABETIC DRUG 29 53% 2% 38
3 INCIDENT CANCER 24 56% 2% 29
4 MITOGENIC POTENCY 18 89% 0% 8
5 PRESURGICAL TRIAL 12 86% 0% 6
6 PHENFORMIN 10 42% 1% 18
7 ANALOG GLARGINE 9 50% 1% 13
8 ANTIDIABETIC DRUG METFORMIN 8 26% 2% 27
9 INSULIN USE 7 57% 0% 8
10 INCREASED MITOGENIC POTENCY 6 100% 0% 4

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Metformin in Cancer Treatment and Prevention 2015 5 63 67%
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis 2012 131 90 70%
Metformin and the Risk of Cancer Time-related biases in observational studies 2012 75 56 89%
Update on breast cancer risk prediction and prevention 2015 5 53 26%
Synergistic Effect of Phenformin in Non-Small Cell Lung Cancer (NSCLC) Ionizing Radiation Treatment 2015 2 15 53%
Diabetes mellitus and cancer risk: Review of the epidemiological evidence 2013 46 47 60%
Metformin-mode of action and clinical implications for diabetes and cancer 2014 52 164 20%
Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies 2013 31 57 81%
Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer 2013 29 48 77%
Cellular and molecular mechanisms of metformin: an overview 2012 224 151 25%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LI KA SHING 2 040 3 60% 0.2% 3
2 SM DELLA MISERICORDIA HOSP 3 60% 0.2% 3
3 HONG KONG DIABET OBES 2 12% 1.0% 17
4 MED ONCOL B SCI DIRECT 2 67% 0.1% 2
5 ONKOLOGISKT 2 67% 0.1% 2
6 TORRANCE MEM MED 2 67% 0.1% 2
7 ICM DIABET 2 50% 0.2% 3
8 CARCINOGENESIS ONCOGERONTOL 2 18% 0.5% 9
9 CLIN EPIDEMIOLSAMUEL LUNENFELD 1 100% 0.1% 2
10 EQUIPE BIOL PATHOL CELLULES MELANOCYTAIRE PIGME 1 100% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000119496 SVFP//ECREIN//ADIPOR2
2 0.0000099630 FAMILIAL PANCREATIC CANCER//CLIN MOL EPIDEMIOL CANC UNIT//PANCREATIC CANCER SUSCEPTIBILITY
3 0.0000097018 NUTR HORMONES UNIT//ENDOMETRIAL CANCER RISK//ENDOMETRIAL NEOPLASMS
4 0.0000083411 IGF 1R//INSULIN LIKE GROWTH FACTOR 1 RECEPTOR//IGF IR
5 0.0000075202 COLORECTAL ADENOMA//COLORECTAL ADENOMAS//RED MEAT
6 0.0000073892 AMPK//AMP ACTIVATED PROTEIN KINASE//AICAR
7 0.0000070678 UNIV INTEGRATED HOSP//DUKE PROSTATE//FREE TESTOSTERONE FT
8 0.0000063728 METFORMIN//LACTIC ACIDOSIS//METFORMIN ASSOCIATED LACTIC ACIDOSIS
9 0.0000058098 REPRODUCTIVE FACTORS//AGE AT FIRST FULL TERM PREGNANCY//AGE AT LAST BIRTH
10 0.0000055312 SERV INTEGRATO EPIDEMIOL SISTEMI INFORMAT//HLTH HLTH SERV//CARCINOMA RENAL CELL